Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Pain Symptom Manage. 2019 Jul 23;58(5):756–765. doi: 10.1016/j.jpainsymman.2019.07.016

Table 2 –

Multiple Logistic Regression Analysis Predicting Change in the Way Food Tastes Group Membership (n = 1280)

Predictor Odds Ratio (95% CI) p-value
Cancer diagnosis 0.019
 Gastrointestinal vs. breast 0.86 (0.63, 1.16) 0.313
 Gynecological vs. breast 0.70 (0.49, 0.99) 0.046
 Lung vs. breast 0.55 (0.36, 0.83) 0.004
Antiemetic regimen 0.001
 Steroid alone or serotonin receptor antagonist alone vs. none 1.48 (0.86, 2.54) 0.160
 Serotonin receptor antagonist and steroid vs. none 1.45 (0.87, 2.41) 0.149
 NK-1 receptor antagonist and two other antiemetics vs. none 2.51 (1.47, 4.29) 0.001
Dry mouth 1.44 (1.11, 1.86) 0.006
Nausea 1.39 (1.07, 1.81) 0.014
Feeling bloated 1.34 (1.02, 1.77) 0.037
Lack of appetite 2.31 (1.76, 3.02) <0.001
Increased appetite 1.56 (1.17, 2.08) 0.003
Difficult swallowing 1.87 (1.26, 2.78) 0.002
Mouth sores 1.57 (1.15, 2.16) 0.005
Constipation 1.50 (1.16, 1.94) 0.002
Overall model fit: degrees of freedom = 17; X2 = 257.55, p < .001

Abbreviations: NK-1 = neurokinin 1, vs = versus